Targeted cancer therapy: the initial high concentration may slow down the selection for resistance (IMAGE)

Impact Journals LLC

Targeted cancer therapy: the initial high concentration may slow down the selection for resistance

Caption

Figure 2. One of my targeted combinations. Capmatinib – standard everyday use. All other medications - reverse dose application -are given on day 1 only. The number of tablets on day1 are shown.

Credit

2024 Blagosklonny et al.

Usage Restrictions

Original content

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.